Lv1
36 积分 2024-02-22 加入
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
3个月前
已完结
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis
3个月前
已完结
Advances in systemic therapies for triple negative breast cancer
3个月前
已完结
Advances in systemic therapies for triple negative breast cancer
3个月前
已完结
A workflow for statistical analysis andvisualization of microbiome omicsdata usingthe Rmicroeco package
3个月前
已完结
Towards targeting the breast cancer immune microenvironment
4个月前
已完结
Inflammatory breast cancer response to modern neoadjuvant chemotherapy: Tumor response and survival outcomes
4个月前
已完结
How to Define Inflammatory Breast Cancer: A Systematic Review
5个月前
已完结
Intra-tumoral bacteria in breast cancer and intervention strategies
6个月前
已完结
Intraoperative evaluation of tumor margins using a TROP2 near-infrared imaging probe to enable human breast-conserving surgery
6个月前
已完结
皖公网安备34019202002308
